(Q35106393)

6 August 2017

1 reference

title

Cytokines, stress and depressive illness: brain-immune interactions (English)

1 reference

6 August 2017

Cytokines, stress and depressive illness: brain‐immune interactions (English)

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

23 December 2023

author name string

Hymie Anisman

1

1 reference

6 August 2017

Zul Merali

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

35

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

2-11

1 reference

Stress and immunity in humans: a meta-analytic review

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

The syntax of immune-neuroendocrine communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

Borderline hypothyroidism and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

Immune correlates of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

Major depression and activation of the inflammatory response system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

Acute phase proteins in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890310004075

Dysthymia: a review of pharmacological and behavioral factors

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/SJ.MP.4000697

Anhedonic and anxiogenic effects of cytokine exposure

1

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Stress and affective disorders in humans

23 December 2023

2

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Acute stress enhances while chronic stress suppresses skin immunity. The role of stress hormones and leukocyte trafficking

23 December 2023

3

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Pituitary control of immune cells

23 December 2023

6

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition

23 December 2023

10

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

The impact of stressors on immune and central neurotransmitter activity: bidirectional communication

23 December 2023

12

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Cytokine-induced sickness behaviour: mechanisms and implications

23 December 2023

15

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Cytokines, "depression due to a general medical condition," and antidepressant drugs

23 December 2023

16

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Pregneolone--from Selye to Alzheimer and a model of the pregnenolone sulfate binding site on the GABAA receptor

23 December 2023

18

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation.

23 December 2023

19

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Cytokine-cytokine interactions and the brain

23 December 2023

21

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Annual review prize lecture cytokines - killers in the brain?

23 December 2023

22

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-alpha

23 December 2023

23

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness

23 December 2023

24

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Hypophysiotropic role and hypothalamic gene expression of corticotropin-releasing factor and vasopressin in rats injected with interleukin-1 beta systemically or into the brain ventricles

23 December 2023

26

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Mouse tumor necrosis factor-alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice

23 December 2023

27

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Ciba Foundation Symposium

23 December 2023

28

172

296

Owens MJ

1993

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations.

23 December 2023

29

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress

23 December 2023

30

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Influence of interleukin-1beta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice

23 December 2023

31

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Psychopharmacology of affective disorders in the 21st century.

23 December 2023

32

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms

23 December 2023

34

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1beta in the male Rat

23 December 2023

35

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Effect of central and continuous intravenous injection of interleukin-1 beta on brain c-fos expression in the rat: involvement of prostaglandins.

23 December 2023

36

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisms

23 December 2023

37

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Euthyroid Sick Syndrome and the role of cytokines

23 December 2023

39

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

The cellular neurobiology of depression

23 December 2023

41

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

A role for interleukin-2 in the regulation of striatal dopaminergic function

23 December 2023

43

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2.

23 December 2023

44

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Alpha-1-acid glycoprotein in major depressive disorder

23 December 2023

48

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Inflammatory markers in major depression and melancholia

23 December 2023

49

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Indicators of immune activation in depressed patients

23 December 2023

50

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

23 December 2023

52

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders

23 December 2023

53

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Increased soluble interleukin-2 receptor concentrations in suicide attempters.

23 December 2023

54

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine

23 December 2023

55

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features

23 December 2023

56

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

The relationship of depression and stressors to immunological assays: a meta-analytic review

23 December 2023

59

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Biological and clinical validation of atypical depression.

23 December 2023

62

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features

23 December 2023

65

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

23 December 2023

67

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.

23 December 2023

68

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.

23 December 2023

69

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration

23 December 2023

70

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

Lowered Serum Dipeptidyl Peptidase IV Activity is Associated with Depressive Symptoms and Cytokine Production in Cancer Patients Receiving Interleukin-2-Based Immunotherapy

23 December 2023

72

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

American Journal of Psychiatry

23 December 2023

74

156: 1120

Miyaoka H

1999

1 reference

https://api.crossref.org/works/10.1080/07853890310004075

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference